Clinical efficacy and safety of alemtuzumab in postmarketing practice

by N. V. Khachanova
Published 2019-06-01

Dimethyl fumarate: the new tableted preparation for the treatment of multiple sclerosis

by E. V. Popova, N. V. Khachanova, N. Y. Lasch, Е. V. Orlova, A. N. Boyko
Published 2015-12-01

Natalizumab in the treatment of multiple sclerosis. Experience of the Moscow Multiple Sclerosis Center (MMSC)

by E. V. Popova, A. N. Boyko, M. V. Davydovskaya, O. V. Boyko, N. V. Khachanova
Published 2014-12-01

TERIFLUNOMIDE - A NEW TABLETED DRUG FOR THERAPY OF REMITTING DISSEMINATED SCLEROSIS (REVIEW)

by E. V. POPOVA, A. N. BOYKO, M. V. DAVYDOVSKAYA, S. N. ZOLOTOVA, N. V. KHACHANOVA, S. N. SHARANOVA
Published 2016-12-01

Safety of generic fingolimod

by O. M. Koval, N. V. Khachanova, M. V. Zhuravleva, A. G. Fisun, M. V. Davydovskaya, K. A. Kokushkin
Published 2018-03-01

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»

by N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
Published 2019-12-01

Fingolimod for the treatment of remitting multiple sclerosis: experience of the Moscow Multiple Sclerosis Center (MMSC)

by E. V. Popova, A. A. Yalymov, A. N. Boyko, M. V. Davydovskaya, E. V. Kolyak, O. V. Traktirskaya, N. V. Khachanova, S. G. Schur
Published 2014-12-01

Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

by A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
Published 2021-06-01

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis

by D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva
Published 2021-02-01

COVID-19 vaccination guidelines for patients with multiple sclerosis

by N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
Published 2021-04-01

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

by A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Published 2019-11-01